ALgerian Cholecystectomy Outcomes and Determinants Study (AL-CODS)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-01

Study Completion Date

2025-07-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cholecystectomy, the surgical removal of the gallbladder, is a common procedure performed to treat benign gallbladder diseases such as cholelithiasis (gallstones), cholecystitis (inflammation of the gallbladder), and biliary dyskinesia. While generally considered safe, this surgery can be associated with significant morbidity and mortality, particularly in certain populations or healthcare settings. Understanding these outcomes and the factors influencing them is crucial for improving patient care and surgical practices.

In Algeria, the healthcare landscape presents unique challenges and opportunities for evaluating surgical outcomes. Limited studies have specifically focused on the morbidity and mortality associated with cholecystectomy in this context. This study aims to fill that gap by providing comprehensive data on 30-day postoperative outcomes following cholecystectomy for benign gallbladder diseases in Algeria. Such data is essential for benchmarking current practices, identifying areas for improvement, and ultimately enhancing patient safety and surgical efficacy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intraoperative Spillage of Bile and Gallstones During Laparoscopic Cholecysetectomy

NCT04041726

Cholecystitis; Gallstone

UNKNOWN

Surgical Practices in Algeria : the Cholecystectomy

NCT04270357

General Surgery Cholecystectomy Practice Guidelines as Topic

COMPLETED

Factors Influencing Occurrence of Bile Leaks in Surgery

NCT04665427

Bile Leak Anastomotic Leak Biliary Biliary Tract Fistula

COMPLETED NA

Clinical Study of Single Incision Laparoscopic Cholecystectomy in the Treatment of Patients With Acute Cholecystitis

NCT06074679

Cholecystectomy, Laparoscopic

RECRUITING NA

Oxidative Stress in Standard Laparoscopic vs Single Port Cholecystectomy

NCT01211743

Uncomplicated Cholelithiasis Cholecystectomy Laparoscopy +2 more

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study seeks to bridge this knowledge gap by offering detailed data on 30-day postoperative outcomes after cholecystectomy for benign gallbladder diseases in Algeria. This information is crucial for benchmarking existing practices, pinpointing areas for enhancement, and ultimately improving patient safety and surgical effectiveness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cholecystectomy Adults Gall Stone Polyps Pancreatitis Biliary Gallbladder Dyskinesia Cholecystitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cholecystectomy

patient opérated ( cholecystectomy) and responding to inclusion criteria

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 years and older.
* Undergoing cholecystectomy.
* Surgery performed in public or private hospitals in Algeria.
* Surgery performed from January 1, 2025, to June 30, 2025.

Exclusion Criteria

* Patients younger than 18 years.
* Patients refusing to participate.
* Cholecystectomy performed for Gallbladder cancer.
* Cholecystectomy performed outside the inclusion period.
* Cholecystectomies performed in conjunction with other major surgeries.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No